BioWorld

June 13, 2000

View Archived Issues

European Patent Disclosures

Read More

Hemosol Completes Phase III Study of Blood Substitute

Read More

Gilead Launches 600-Patient Phase III Trial Of Tenofovir

Read More

Other News To Note

Read More

Recap Of Deals, Financings Now Available From BioWorld

Read More

Stubby Peptide Fragment of Huge Fibronectin Sequence Heals Model Wounds In Obese Diabetic Rodents

Read More

Ibis, Agouron Sign $37M Deal To Develop RNA Binding Drugs

Read More

J&J Terminates Alkermes Deal For Sustained-Release EPO

Read More